Q2 FY2026 EarningsQ2 FY26 results slightly beat consensus on adjusted profitability despite a minor revenue miss. Revenue of $4.42B was marginally below the $4.39B mean estimate, while adjusted EPS reached $2.09 vs. the $2.08 consensus. Growth was driven by the Global Life Sciences (+15%) and Global Pest Elimination (+7%) segments, while the Global Water segment's margins were pressured by business investments and commodity costs. Management successfully offset inflationary pressures through pricing, supporting a stable adjusted tax rate of 21.0% in line with expectations.